多发性-话题@MedSci

#多发性#

905篇内容 | 3004人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890191, encodeId=5231189019114, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NICE指南支持isatuximab治疗多发性骨髓瘤（MM）, objectType=article, longId=203866, objectId=3f4520386600, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f4520386600, replyNumber=0, likeNumber=0, createdTime=2021-01-24, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f4520386600, moduleTitle=NICE指南支持isatuximab治疗多发性骨髓瘤（MM）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f4520386600)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890150, encodeId=3686189015026, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:多发性硬化症患者的纳比昔莫停药率,一项为期18个月的多中心研究, objectType=article, longId=199495, objectId=312b199495ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=312b199495ab, replyNumber=0, likeNumber=0, createdTime=2021-04-06, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=312b199495ab, moduleTitle=JNNP:多发性硬化症患者的纳比昔莫停药率,一项为期18个月的多中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=312b199495ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890114, encodeId=c895189011410, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Brit J Heamatol：接受免疫调节剂治疗的多发性骨髓瘤患者静脉血栓栓塞的一级预防, objectType=article, longId=193111, objectId=2a19193111d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a19193111d1, replyNumber=0, likeNumber=66, createdTime=2021-01-04, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a19193111d1, moduleTitle=Brit J Heamatol：接受免疫调节剂治疗的多发性骨髓瘤患者静脉血栓栓塞的一级预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a19193111d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890178, encodeId=144618901e8af, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：del(17p)指示多发性骨髓瘤患者预后不良, objectType=article, longId=202898, objectId=cf162028984d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf162028984d, replyNumber=0, likeNumber=94, createdTime=2021-09-27, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf162028984d, moduleTitle=Blood：del(17p)指示多发性骨髓瘤患者预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf162028984d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890154, encodeId=a44a189015413, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Acta Neuropathologica:多发性硬化的髓鞘再生受损的病变阶段相关原因分析, objectType=article, longId=199881, objectId=2bd0199881df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bd0199881df, replyNumber=0, likeNumber=73, createdTime=2020-09-15, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bd0199881df, moduleTitle=Acta Neuropathologica:多发性硬化的髓鞘再生受损的病变阶段相关原因分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bd0199881df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890100, encodeId=1f61189010011, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood Cancer Journal：一种检测多发性骨髓瘤多种耐药性的新技术, objectType=article, longId=190239, objectId=8ff6190239d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ff6190239d0, replyNumber=0, likeNumber=72, createdTime=2020-05-05, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ff6190239d0, moduleTitle=Blood Cancer Journal：一种检测多发性骨髓瘤多种耐药性的新技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ff6190239d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890113, encodeId=9806189011358, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比, objectType=article, longId=192943, objectId=28a119294391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28a119294391, replyNumber=0, likeNumber=0, createdTime=2021-02-12, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28a119294391, moduleTitle=Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28a119294391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890139, encodeId=cd18189013940, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：一种新的高还原的多发性骨髓瘤小鼠模型, objectType=article, longId=197685, objectId=02a619e68506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02a619e68506, replyNumber=0, likeNumber=48, createdTime=2021-04-17, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02a619e68506, moduleTitle=Blood：一种新的高还原的多发性骨髓瘤小鼠模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02a619e68506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890087, encodeId=b603189008ec6, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Lancet：Daratumumab联合疗法用于改善多发性骨髓瘤患者总生存期, objectType=article, longId=186076, objectId=871f1860e69e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=871f1860e69e, replyNumber=0, likeNumber=102, createdTime=2020-01-31, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=871f1860e69e, moduleTitle=Lancet：Daratumumab联合疗法用于改善多发性骨髓瘤患者总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=871f1860e69e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890162, encodeId=a88c189016292, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Clin Cancer Res：抗ICAM1抗体-药物偶联物用于多发性骨髓瘤的潜在活性, objectType=article, longId=200931, objectId=c7f6200931f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7f6200931f1, replyNumber=0, likeNumber=65, createdTime=2021-01-26, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7f6200931f1, moduleTitle=Clin Cancer Res：抗ICAM1抗体-药物偶联物用于多发性骨髓瘤的潜在活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7f6200931f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890078, encodeId=054718900e8d8, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=疗效与安全并举，聚焦来那度胺在多发性骨髓瘤维持治疗中的多项重磅进展, objectType=article, longId=184325, objectId=8ad51843258c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ad51843258c, replyNumber=0, likeNumber=70, createdTime=2020-03-29, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ad51843258c, moduleTitle=疗效与安全并举，聚焦来那度胺在多发性骨髓瘤维持治疗中的多项重磅进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ad51843258c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890133, encodeId=3dfa18901330f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：在多发性骨髓瘤中，单克隆免疫球蛋白促进骨丢失, objectType=article, longId=196564, objectId=f010196564d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f010196564d8, replyNumber=0, likeNumber=88, createdTime=2021-01-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f010196564d8, moduleTitle=Blood：在多发性骨髓瘤中，单克隆免疫球蛋白促进骨丢失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f010196564d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890135, encodeId=08ba18901357f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Brit J Heamatol：血清BDNF浓度预测多发性骨髓瘤患者的多发性神经病和总生存期, objectType=article, longId=196878, objectId=8a431968e8b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a431968e8b4, replyNumber=0, likeNumber=93, createdTime=2020-11-29, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a431968e8b4, moduleTitle=Brit J Heamatol：血清BDNF浓度预测多发性骨髓瘤患者的多发性神经病和总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a431968e8b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890165, encodeId=d4031890165fc, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Clin Cancer Res：MYC重排对多发性骨髓瘤患者预后的影响, objectType=article, longId=201576, objectId=97082015e651, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97082015e651, replyNumber=0, likeNumber=65, createdTime=2020-10-14, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97082015e651, moduleTitle=Clin Cancer Res：MYC重排对多发性骨髓瘤患者预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97082015e651)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890102, encodeId=42df189010207, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=FDA准许开展IMS001治疗多发性硬化症的临床计划, objectType=article, longId=190580, objectId=83341905808f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83341905808f, replyNumber=0, likeNumber=102, createdTime=2020-05-04, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83341905808f, moduleTitle=FDA准许开展IMS001治疗多发性硬化症的临床计划, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83341905808f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890101, encodeId=6d971890101f0, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Ponesimod治疗成人多发性硬化症：强生已向美国FDA提交新药申请（NDA）, objectType=article, longId=190437, objectId=1dee19043e93, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1dee19043e93, replyNumber=0, likeNumber=77, createdTime=2020-08-02, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1dee19043e93, moduleTitle=Ponesimod治疗成人多发性硬化症：强生已向美国FDA提交新药申请（NDA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1dee19043e93)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890080, encodeId=2e23189008092, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=DARZALEX（Daratumumab）方案显著增加复发难治多发性骨髓瘤患者的PFS, objectType=article, longId=184567, objectId=14fb18456e61, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14fb18456e61, replyNumber=0, likeNumber=97, createdTime=2020-04-14, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14fb18456e61, moduleTitle=DARZALEX（Daratumumab）方案显著增加复发难治多发性骨髓瘤患者的PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14fb18456e61)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890130, encodeId=9a321890130eb, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JAMA Neurol：钩虫感染可调节免疫应答或可改善多发性硬化症状, objectType=article, longId=196292, objectId=866119629287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=866119629287, replyNumber=0, likeNumber=84, createdTime=2020-07-07, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=866119629287, moduleTitle=JAMA Neurol：钩虫感染可调节免疫应答或可改善多发性硬化症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=866119629287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890099, encodeId=99e41890099b3, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=CELL：膳食纤维经肠道细菌加工后影响多发性硬化病程, objectType=article, longId=190078, objectId=e4541900e8f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4541900e8f4, replyNumber=0, likeNumber=69, createdTime=2020-11-13, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4541900e8f4, moduleTitle=CELL：膳食纤维经肠道细菌加工后影响多发性硬化病程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4541900e8f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890145, encodeId=71491890145a9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=引领多发性硬化治疗新纪元——承诺中华，不负所托, objectType=article, longId=198992, objectId=74e21989926a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74e21989926a, replyNumber=0, likeNumber=66, createdTime=2021-06-12, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74e21989926a, moduleTitle=引领多发性硬化治疗新纪元——承诺中华，不负所托, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74e21989926a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NICE指南支持isatuximab治疗多发性骨髓瘤（MM）

2021-01-24

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:多发性硬化症患者的纳比昔莫停药率,一项为期18个月的多中心研究

2021-04-06

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Brit J Heamatol：接受免疫调节剂治疗的多发性骨髓瘤患者静脉血栓栓塞的一级预防

2021-01-04

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：del(17p)指示多发性骨髓瘤患者预后不良

2021-09-27

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Acta Neuropathologica:多发性硬化的髓鞘再生受损的病变阶段相关原因分析

2020-09-15

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood Cancer Journal：一种检测多发性骨髓瘤多种耐药性的新技术

2020-05-05

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比

2021-02-12

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：一种新的高还原的多发性骨髓瘤小鼠模型

2021-04-17

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Lancet：Daratumumab联合疗法用于改善多发性骨髓瘤患者总生存期

2020-01-31

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Clin Cancer Res：抗ICAM1抗体-药物偶联物用于多发性骨髓瘤的潜在活性

2021-01-26

jml2009 (审核中...)

前往app查看评论内容

#多发性#

疗效与安全并举，聚焦来那度胺在多发性骨髓瘤维持治疗中的多项重磅进展

2020-03-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：在多发性骨髓瘤中，单克隆免疫球蛋白促进骨丢失

2021-01-08

zhaojie88 (审核中...)

前往app查看评论内容

#多发性#

Brit J Heamatol：血清BDNF浓度预测多发性骨髓瘤患者的多发性神经病和总生存期

2020-11-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Clin Cancer Res：MYC重排对多发性骨髓瘤患者预后的影响

2020-10-14

jml2009 (审核中...)

前往app查看评论内容

#多发性#

FDA准许开展IMS001治疗多发性硬化症的临床计划

2020-05-04

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Ponesimod治疗成人多发性硬化症：强生已向美国FDA提交新药申请（NDA）

2020-08-02

jml2009 (审核中...)

前往app查看评论内容

#多发性#

DARZALEX（Daratumumab）方案显著增加复发难治多发性骨髓瘤患者的PFS

2020-04-14

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JAMA Neurol：钩虫感染可调节免疫应答或可改善多发性硬化症状

2020-07-07

jml2009 (审核中...)

前往app查看评论内容

#多发性#

CELL：膳食纤维经肠道细菌加工后影响多发性硬化病程

2020-11-13

jml2009 (审核中...)

前往app查看评论内容

#多发性#

引领多发性硬化治疗新纪元——承诺中华，不负所托

2021-06-12

科室
- - 订阅+
  - 更多科室
工具
服务